Literature DB >> 16876891

Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial.

Maria Elenita Favarato1, Whady Hueb, William E Boden, Neuza Lopes, Célia Regina Simões da Rocha Nogueira, Myrthes Takiuti, Aécio F T Góis, Jorge C Borges, Desiderio Favarato, Jose Mendes Aldrighi, Sérgio Almeida Oliveira, José A F Ramires.   

Abstract

OBJECTIVE: We evaluated the impact of Coronary Artery Bypass Graft Surgery (CABG), Percutaneous Coronary Intervention (PCI) or Medical Therapy (MT) on self-perceived quality of life among patients with stable Coronary Artery Disease (CAD).
BACKGROUND: The Medicine, Angioplasty and Surgery Study (MASS-II) implemented initial policies of CABG, PCI or continued medical treatment in patients who allow assessment of mid-term health consequences.
METHODS: A total of 542 patients were randomly assigned to CABG (175), to PCI (180) and to MT (187). The short form 36 (SF-36) self-administered quality of life (QoL) questionnaires were applied at baseline, 6 months and 12 months later.
RESULTS: All the three therapeutic strategies presented significant improvement in all dimensions of the SF-36 during the follow-up (p<0.0001). However, the CABG group was the one that had significantly greater improvement in physical and social functioning, vitality and general health when compared to MT and PCI. Also, men had the best QoL at the beginning of the treatment when compared to women, with a progressive improvement after 6 and 12 months.
CONCLUSIONS: The quality of life was better in both CABG and PCI groups compared to MT after 1 year of follow-up. However, the patients submitted to CABG were the ones that presented the greater and progressive improvement of QoL. Also, men presented better QoL at the beginning and after treatment when compared to women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876891     DOI: 10.1016/j.ijcard.2006.06.001

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program.

Authors:  Irene Lie; Harald Arnesen; Leiv Sandvik; Glenys Hamilton; Eli H Bunch
Journal:  Qual Life Res       Date:  2009-01-25       Impact factor: 4.147

2.  Optimal treatment of multivessel complex coronary artery disease.

Authors:  Haihui Sun; Lianqun Cui
Journal:  Exp Ther Med       Date:  2014-03-21       Impact factor: 2.447

3.  Impact of invasive treatment strategy on health-related quality of life six months after non-ST-elevation acute coronary syndrome.

Authors:  Li-Xia Yang; Yu-Jie Zhou; Zhi-Jian Wang; Yue-Ping Li; Meng Chai
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

Review 4.  Comparison of the Postprocedural Quality of Life between Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention: A Systematic Review.

Authors:  Kaneez Fatima; Mohammad Yousuf-Ul-Islam; Mehreen Ansari; Faizan Imran Bawany; Muhammad Shahzeb Khan; Akash Khetpal; Neelam Khetpal; Muhammad Nawaz Lashari; Mohammad Hussham Arshad; Raamish Bin Amir; Hoshang Rustom Kakalia; Qaiser Hasan Zaidi; Sharmeen Kamran Mian; Bahram Kazani
Journal:  Cardiol Res Pract       Date:  2016-02-18       Impact factor: 1.866

5.  Quality of life in patients after coronary artery bypass grafting with bilateral internal thoracic artery versus single internal thoracic artery.

Authors:  Marcin Zębalski; Jarosław Bis; Michał Krejca; Marek A Deja
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-04-07

6.  Impact of patient's health-related quality of life on physicians' therapy and perceived benefit in acute coronary syndromes: protocol for a systemic review of quantitative and qualitative studies.

Authors:  Billingsley Kaambwa; Hailay Gesesew; Matthew Horsfall; Derek P Chew
Journal:  BMJ Open       Date:  2019-02-27       Impact factor: 2.692

7.  Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.

Authors:  Alexandra N Nowbar; Darrel P Francis; Rasha K Al-Lamee
Journal:  Cardiovasc Drugs Ther       Date:  2021-08-21       Impact factor: 3.947

8.  Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial.

Authors:  Ariane Drouin; Nicolas Noiseux; Carl Chartrand-Lefebvre; Gilles Soulez; Samer Mansour; Jan-Alexis Tremblay; Fadi Basile; Ignacio Prieto; Louis-Mathieu Stevens
Journal:  Trials       Date:  2013-08-26       Impact factor: 2.279

9.  Quality of Life Changes in Acute Coronary Syndromes Patients: A Systematic Review and Meta-Analysis.

Authors:  Billingsley Kaambwa; Hailay Abrha Gesesew; Matthew Horsfall; Derek Chew
Journal:  Int J Environ Res Public Health       Date:  2020-09-21       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.